[ORGANIZATION]
Abras
Featured in 6 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
311 clusters · 1155 sources · last updated
Latest: GLP-1 receptor agonists linked to weight loss in peritoneal dialysis patients
The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health, with some scientists suggest
Also covered in
-
Vale do Taquari Food and Beverage APL expands network and AI training
[BUSINESS] · 2 sources ·
-
GIC Brasil expands to pharmaceutical retail at ABRAS convention
[BUSINESS] · 6 sources ·